ALBERTO LARRIEU: Open Payments
NPI 1447209614 · FEASTERVILLE TREVOSE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$410 in 10 payments from 6 companies in 2025. Trend: 2023 $486 · 2024 $1,319 · 2025 $410
Food & beverage: $410
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $174 |
| Neurocrine BioSciences, Inc. | 1 | $128 |
| Braeburn Inc. | 2 | $42 |
| REVANCE THERAPEUTICS, INC. | 1 | $33 |
| ABBVIE INC. | 1 | $19 |
| Galderma Laboratories, L.P. | 1 | $15 |
Products named: REXULTI, INGREZZA, BRIXADI, DAXXIFY, MAVYRET.
Industry payments across PA — which companies pay providers there.
